molecular analysis of bladder cancer from asco 2017: clinical implications
Published 3 years ago • 4 plays • Length 5:21Download video MP4
Download video MP3
Similar videos
-
8:32
the role of molecular markers in bladder cancer from asco gu 2017
-
8:56
clinical implications of molecular subtypes in bladder cancer and updates on germ cell tumor therapy
-
8:11
bladder cancer highlights from asco gu 2017: clinical implications
-
5:38
key data on bladder cancer from asco gu 2017
-
8:26
the role of molecular markers in bladder cancer
-
8:04
bladder cancer highlights: clinical implications
-
2:10
chemoradiotherapy for bladder cancer: clinical relevance of data from asco gu 2017
-
4:34
chemoradiation in bladder cancer: a review from asco gu 2017
-
2:16
chemoradiotherapy for bladder cancer: clinical relevance of data from asco gu 2017
-
43:48
urinary molecular marker tests in bladder cancer: an overview of cxbladder
-
1:10
highlights in bladder cancer from asco 2022
-
4:18
non-muscle invasive and muscle invasive bladder cancer data from asco gu 2017
-
1:27
highlights in kidney and bladder cancer at asco 2023
-
3:31
prominent bladder cancer presentations at asco
-
6:13
key features of micropapillary urothelial carcinoma and their clinical implications
-
7:45
analysis of recurrence after neoadjuvant bladder cancer treatment: practical implications
-
1:33
hot topics in bladder cancer from asco gu 2023
-
6:43
major trial data from asco gu 2017: an overview
-
32:19
asco updates 2020: bladder cancer with dr. manoj bupathi